Altos Labs — Startup Profile
Cellular rejuvenation programming to reverse disease and transform medicine
HQ: Redwood City, California, United States | Founded: 2022 | Employees: Unknown | Stage: Late Stage VC | Website: https://www.altoslabs.com
About
Altos Labs is a biotechnology company focused on cellular rejuvenation programming — a therapeutic approach aimed at restoring cell health and resilience by reversing the cellular damage associated with aging. The company's stated goal is to develop treatments that can reverse disease processes, fundamentally altering how medicine addresses age-related conditions. Its work sits at the intersection of epigenetics, regenerative medicine, and computational biology.
The Take
Altos Labs is a well-capitalized biotechnology startup pursuing cellular rejuvenation — reprogramming cells to reverse aging — with a founding team drawn from the upper ranks of pharma and academic science, but with no disclosed revenue, funding history, or clinical milestones to validate its commercial trajectory.
Key Metrics
- Latest Valuation: Undisclosed
- Last Round: Undisclosed
- Total Funding: Undisclosed
- Headcount: Undisclosed
- Founded: 2022
- Est. Runway: 0 months
Funding Rounds
- Round: Undisclosed (2022-01-01) — Undisclosed
- Round: Undisclosed (2022-06-01) — Undisclosed
Key People
- Hal V. Barron
- Hans E. Bishop
- Rick Klausner
Key Competitors
- Calico (Alphabet) —
- Unity Biotechnology —
- Turn Biotechnologies —
Timeline Highlights
- 2022-06-01: Research Operations Begin
- 2022-01-19: Public Launch
- 2022-01-01: Company Founded
Recent News
- Altos Labs Emerges as Major Bet on Longevity Science (2022-01-19)
- Altos Labs Company Overview — Cellular Rejuvenation Programming (2023-06-01)
Similar Startups
- Solugen — Bio-based chemical manufacturing via a modular enzymatic platform
- Benchling — Unified R&D Cloud for life sciences
- Vilya — Computational biotech platform designing novel molecular structures to target disease biology
- Colossal Biosciences — De-extinction and genetic engineering company resurrecting extinct species
- eGenesis — Genome engineering for human-compatible organ transplants
More Biotech Startups
- Vilya — Computational biotech platform designing novel molecular structures to target disease biology
- Insitro — Machine learning-enabled drug discovery and development platform combining high-throughput biology w
- Colossal Biosciences — De-extinction and genetic engineering company resurrecting extinct species
- eGenesis — Genome engineering for human-compatible organ transplants
- Mammoth Biosciences — CRISPR platform company developing diagnostics and therapeutics
Browse: Home | Blog | About | All Startups A-Z | View full profile on StartupWiki